THE IMPULSE BY CHIESI

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jan 2025 filing date already counts against anyone who files later.

Record

Serial number

99001279

Mark type

Design + words

Filed

16 Jan 2025

Published for opposition

04 Nov 2025

Attorney of record

Anthony P. Venturino

Goods and services

• Class 016 — Paper goods and printed matter: Printed pharmaceutical information leaflets; Printed newspapers; Advertising signs of cardboard; personalized writing journals in the field of research and development of medicines and biotechnology; Printed informational sheets about medicines; Printed educational publications, namely, books and workbooks in the fields of research and development of medicines and biotechnology; Printed promotional materials in the nature of postcards and brochures featuring research and development of medicines and biotechnology; Advertisement boards of cardboard; Printed teaching materials in the field of research and development of medicines and biotechnology; Printed manuals, namely, handbooks in the field of research and development of medicines and biotechnology; Printed research reports featuring research and development of medicines and biotechnology; Printed books in the field of research and development of medicines and biotechnology; Printed reports featuring research and development of medicines and biotechnology; Printed matter, namely, paper signs, books, manuals, curricula, newsletters, informational cards and brochures in the field of research and development of medicines and biotechnology; Printed matter, namely, magazines and printed periodicals in the fields of research and development of medicines and biotechnology; Art prints; Printed professional magazines in the field of research and development of medicines and biotechnology
• Class 041 — Education and entertainment services: Publishing of journals, books and handbooks in the field of medicine; Educational services, namely, conducting seminars in the field of medicine, science and biotechnology; Organization and conducting of seminars in the field of medicine, science and biotechnology; Teaching in the field of medicine; Publication of the results of clinical trials for pharmaceutical preparations; Arranging and conducting of training courses in the field of medicine, science and biotechnology; Organization of conferences and symposia in the field of medical science; Personnel training for others; Arranging and conducting of training courses in the field of medicine, science and biotechnology; Providing advice relating to medical and biotechnology training; Providing instructional teaching services in the field of medical and biotechnology field; Conducting of educational seminars relating to medical matters; Educational services, namely, training workers in the healthcare sector; Education services, namely, providing tutorial sessions in the field of medicine, science and biotechnology; Training services, namely, conducting classes and training in the field of medical disorders and their treatment; Education services, namely, conducting classes in the field of pharmacy; Publishing of scientific papers in the field of respiratory diseases, rare and ultra-rare diseases, and consumer healthcare products; Publishing and issuing scientific papers in the field of medical technology; Organization of seminars and conventions in the field of medicine; Providing continuing medical education services, namely, live and online courses; Educational services, namely, production of audio/visual presentations for others; Arranging and conducting of workshops and training at professional seminars in the fields of medicines and biotechnology and production of course material distributed therewith; Arranging of lectures in the field of medicines an biotechnology; Conducting workshops for educational purposes for organizations in the field of medicines and biotechnologies
• Class 042 — Scientific and technological services: Pharmaceutical products development; Providing medical and scientific research information about the results of clinical trials for pharmaceutical products; Pharmaceutical product evaluation; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Biological research; Biological research and analysis; Research and development for the pharmaceutical industry; Consultancy relating to pharmaceutical research and development; Advisory services relating to biochemistry; Technical consultation in the field of information technology services for the pharmaceutical and healthcare industries; Biomedical research services; Computer technological consultancy in the field of clinical trials and pharmaceutical products; Advisory services relating to science, namely, providing scientific information, advice and consultancy in the field of clinical trials and administration of pharmaceutical products; Pharmaceutical research in the field of pharmaceuticals; Consultancy pertaining to pharmacology
• Class 044 — Medical, beauty and agricultural services: Pharmaceutical advice; Consulting services in the field of health care; Professional consulting services in the field of healthcare; Providing medical information; Remote monitoring of medical data for medical diagnosis and treatment; Pharmaceutical compounding services; Providing news and information in the field of medicine; Medical and healthcare clinics; Medical health assessment services; Medical and healthcare services; Providing health care information via a global computer network; Medical screening; Medication counseling; Advisory services relating to pharmaceuticals; Medical information; Medical services for the diagnosis of conditions of the human body

Owner

• CHIESI FARMACEUTICI S.P.A., Parma (PR), IT
• CHIESI FARMACEUTICI S.P.A., Parma (PR), IT

Prosecution history

• 10 Sept 2026 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
• 10 Sept 2026 — NOTICE OF ALLOWANCE CANCELLED
• 21 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 26 Jun 2026 — SOU TEAS EXTENSION RECEIVED
• 26 Jun 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
• 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 04 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 04 Nov 2025 — PUBLISHED FOR OPPOSITION
• 29 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 23 Sept 2025 — WITHDRAWN FROM PUB - OG REVIEW QUERY
• 02 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 29 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 29 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 29 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 27 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED